Xanthine oxidase inhibitory terpenoids of Amentotaxus formosana protect cisplatin-induced cell death by reducing reactive oxygen species (ROS) in normal human urothelial and bladder cancer cells

Abstract

The diterpenoids (+)-ferruginol ( 1), ent-kaur-16-en-15-one ( 2), ent-8(14),15-sandaracopimaradiene-2α,18-diol ( 3), 8(14),15-sandaracopimaradiene-2α,18,19-triol ( 4), and (+)-sugiol ( 5) and the triterpenoids 3 β-methoxycycloartan-24(24 1)-ene ( 6), 3 β,23 β-dimethoxycycloartan-24(24 1)-ene ( 7), 3 β,23 β-dimethoxy-5α-lanosta-24(24 1)-ene ( 8), and 23( S)-23-methoxy-24-methylenelanosta-8-en-3-one ( 9), isolated from Amentotaxus formosana, showed inhibitory effects on xanthine oxidase (XO). Of the compounds tested, compound 5 was a potent inhibitor of XO activity, with an IC 50 value of 6.8 ± 0.4 μM, while displaying weak ABTS radical cation scavenging activity. Treatment of the bladder cancer cell line, NTUB1, with 3–10 μM of compound 5 and 10 μM cisplatin, and immortalized normal human urothelial cell line, SV-HUC1, with 0.3–1 μM and 10–50 μM of compound 5 and 10 μM cisplatin, respectively, resulted in increased viability of cells compared with cytotoxicity induced by cisplatin. Treatment of NTUB1 with 20 μM cisplatin and 10 or 30 μM of compound 5 resulted in decreased ROS production compared with ROS production induced by cisplatin. These results indicate that 10 or 30 μM of compound 5 in NTUB1 cells may mediate through the suppression of XO activity and reduction of reactive oxygen species (ROS) induced by compound 5 cotreated with 20 μM cisplatin and protection of subsequent cell death.